Brainchip Holdings Ltd. (AU:BRN)
OTHER OTC:BRN
Top Page
BrainChip Holdings
(OTC:BRN)
Select Model
Select Model
Rating:48Neutral
Price Target:
AU$0.13
▼(-25.56% Downside)
Action:UpgradedDate:02/28/26
The score is primarily constrained by persistent losses, negative gross profit, and continued cash burn despite accelerating revenue growth and a low-debt balance sheet. Technicals are mixed (neutral oscillators but negative MACD and below longer moving averages), and valuation provides limited support given negative earnings and no dividend data.
Positive Factors
Accelerating revenue growth
Sustained high revenue growth (48.5% YoY in 2025) off a smaller base indicates improving commercialization and product-market fit for Akida. Over 2–6 months this suggests growing customer adoption and a larger addressable revenue runway if the company converts pilots to production and scales sales.
Negative Factors
Persistent large net losses
Consistent multi-year net losses (~A$21–24M) and negative gross profit signal the business has not yet achieved viable unit economics. Over the medium term this pressures cash resources, delays path to sustainable profitability, and heightens dependency on successful product monetization or further funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating revenue growth
Sustained high revenue growth (48.5% YoY in 2025) off a smaller base indicates improving commercialization and product-market fit for Akida. Over 2–6 months this suggests growing customer adoption and a larger addressable revenue runway if the company converts pilots to production and scales sales.
Read all positive factors
BrainChip Holdings (BRN) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$326.85M
Dividend YieldN/A
Average Volume (3M)8.56M
Price to Earnings (P/E)―
Beta (1Y)1.78
Revenue Growth503.29%
EPS Growth11.46%
CountryAU
Employees63
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,275,825,200
10 Day Avg. Volume11,881,565
30 Day Avg. Volume8,562,014
Financial Highlights & Ratios
PEG Ratio0.60
Price to Book (P/B)8.07
Price to Sales (P/S)126.89
P/FCF Ratio-15.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$4.40M
BrainChip Holdings Business Overview & Revenue Model
Company Description
BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence (AI) and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia. The company offers Akida Neuromorphic Proc...
How the Company Makes Money
BrainChip primarily generates revenue by commercializing its Akida™ neuromorphic computing technology through (1) licensing its intellectual property (IP) to customers and partners for integration into their own chips/SoCs and products, and (2) se...
BrainChip Holdings Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
68
Positive
Cash Flow
30
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.95M | 398.01K | 232.00K | 5.07M | 1.59M |
| Gross Profit | -2.59M | -134.91K | 91.44K | 4.59M | 1.30M |
| EBITDA | -19.53M | -23.67M | -27.99M | -21.41M | -20.65M |
| Net Income | -21.18M | -24.43M | -28.88M | -22.09M | -20.98M |
Balance Sheet | |||||
| Total Assets | 34.17M | 23.05M | 20.18M | 29.18M | 23.78M |
| Cash, Cash Equivalents and Short-Term Investments | 31.73M | 20.00M | 14.34M | 23.12M | 19.37M |
| Total Debt | 1.18M | 1.17M | 1.70M | 2.05M | 1.85M |
| Total Liabilities | 3.46M | 3.22M | 3.35M | 5.46M | 4.84M |
| Stockholders Equity | 30.71M | 19.83M | 16.83M | 23.72M | 18.94M |
Cash Flow | |||||
| Free Cash Flow | -16.02M | -15.96M | -17.66M | -19.88M | -13.94M |
| Operating Cash Flow | -15.98M | -15.88M | -17.53M | -19.69M | -13.69M |
| Investing Cash Flow | -2.09M | -72.65K | -132.60K | -127.22K | -265.55K |
| Financing Cash Flow | 29.38M | 22.60M | 8.84M | 17.59M | 14.69M |
BrainChip Holdings Technical Analysis
Positive
0.18
Price Trends
0.14
Positive
0.16
Negative
0.18
Negative
Market Momentum
<0.01
Negative
52.38
Neutral
57.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:BRN, the sentiment is Positive. The current price of 0.18 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.14, and below the 200-day MA of 0.18, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.38 is Neutral, neither overbought nor oversold. The STOCH value of 57.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:BRN.
BrainChip Holdings Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$1.38B | 52.40 | ― | ― | 191.25% | 19.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$253.09M | -2.91 | -44.58% | ― | 19.60% | -59.17% | |
49 Neutral | AU$749.67M | -8.87 | -57.61% | ― | 333.23% | 10.83% | |
48 Neutral | AU$326.85M | ― | -89.98% | ― | 503.29% | 11.46% | |
43 Neutral | AU$22.67M | -6.20 | -112.59% | ― | ― | -67.74% | |
41 Neutral | AU$20.74M | -3.83 | -153.09% | ― | -48.98% | -12.82% |
* Technology Sector Average
AU:BRN
BrainChip Holdings
0.15
-0.03
-17.14%
AU:4DS
4DS Memory
0.01
-0.02
-57.69%
AU:ELS
Elsight Ltd.
6.25
5.90
1685.71%
AU:ACE
Acusensus Ltd
1.50
0.55
57.89%
AU:WBT
Weebit Nano Ltd.
3.55
2.09
143.15%
AU:ICE
iCetana Ltd.
0.04
0.02
143.75%
BrainChip Holdings Corporate Events
BrainChip Sets May AGM Date and Clarifies Neuromorphic Silicon Description
Mar 6, 2026
BrainChip Holdings has clarified an earlier statement, correcting a typographical error to confirm it produces neuromorphic AI IP, silicon and reference designs, rather than “silicone,” underscoring its positioning at the forefront of ...
BrainChip Sets May AGM Date and Director Nomination Deadline
Mar 5, 2026
BrainChip has scheduled its 2026 Annual General Meeting for 6 May in Sydney, and set 12 March as the deadline for shareholders to submit written nominations for board seats with the consent of proposed directors. The formal meeting notice will fol...
BrainChip Updates Director Peter Van Der Made’s Equity Holdings After Rights Vesting
Mar 5, 2026
BrainChip Holdings has disclosed a change in the holdings of director Peter Van Der Made, following the vesting and lapse of performance rights granted to him. As a result of the vesting, he received 171,722 fully paid ordinary shares at no cash c...
BrainChip Updates Director Sean Hehir’s Equity Holdings After RSU Vesting
Mar 5, 2026
BrainChip Holdings has disclosed changes in the equity interests of director Sean Hehir, reflecting the vesting of restricted stock units and subsequent share transactions. Following these changes, Hehir’s holdings increased to 3,857,963 ful...
BrainChip Tightens Investor Relations Framework to Boost Transparency and Market Trust
Feb 26, 2026
BrainChip Holdings’ board has introduced a more disciplined investor relations framework aimed at improving transparency, consistency, and compliance with ASX continuous disclosure rules. The company is consolidating all external communicati...
BrainChip files updated ASX governance statement, reinforcing compliance
Feb 26, 2026
BrainChip Holdings has lodged its updated corporate governance statement for the financial year ended 31 December 2025, confirming that the document is available on its investor website and has been approved by the board as of 18 February 2026. Th...
BrainChip Narrows Loss as Revenue Surges and Asset Backing Improves
Feb 26, 2026
BrainChip posted a sharp rise in revenue from continuing operations to US$1.89 million for the year to 31 December 2025, up 374% on the prior year, while narrowing its operating loss to US$21.71 million and after-tax loss to US$20.47 million. Resu...
BrainChip Boosts Capital and Ramps AKD1500 Production as Defence-Focused Deals Advance
Jan 29, 2026
BrainChip’s December 2025 quarter was marked by steady early-stage commercial traction and a strengthened balance sheet as it pushes to scale its neuromorphic AI platform. Customer cash inflows rose slightly to US$0.4 million while operating...
BrainChip Issues 879,061 New Shares Following Conversion of Unquoted Securities
Jan 7, 2026
BrainChip Holdings has notified the market of the issue of 879,061 new fully paid ordinary shares following the conversion or exercise of previously unquoted options or other convertible securities. The additional shares, effective from 10 Novembe...
BrainChip Reports Lapse of 1.67 Million Restricted Stock Units
Jan 7, 2026
BrainChip Holdings Ltd has notified the market that 1,666,190 restricted stock units (RSUs) under the ASX security code BRNAM have lapsed after the conditions attached to those securities were not met or became incapable of being satisfied as of 3...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.